Protein detail

BOC

Brother of CDO (Protein BOC)

Entry name
BOC
UniProt ID
EVMP confidence score
0.40
Supporting publications (n)
1
Transmembrane count
1
Protein classification
Predicted intracellular proteinsPredicted membrane proteins
Basic Information
Protein Names
Brother of CDO (Protein BOC)
Protein Class (2)
Predicted intracellular proteinsPredicted membrane proteins
Protein Function
Predicted intracellular proteins
Transmembrane
856..876; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym (2)
BoiCDON2
Gene Description
BOC cell adhesion associated, oncogene regulated
Chromosome
3
Position
113211003-113287459
Supporting publications (n)
1
EVMP confidence score
0.40
Fluorescence & Localization
BOC fluorescence
Tissue Specificsalivary glandCell SpecificAstrocytes
Function & Pathway
Relations & Evidence61

Ligand-Receptor Signaling (54)

54 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
plasma_membrane_transmembraneplasma_membrane_transmembraneHPMRYes
plasma_membrane_transmembraneplasma_membrane_transmembraneOmniPathYes
cell_surfacecell_surfaceSurfaceomeYes
cell_surfacecell_surfaceconnectomeDB2020Yes
cell_surfacecell_surfaceOmniPathYes
receptorreceptortalklrYesYes
receptorreceptorCellinkerYesYes
receptorreceptorconnectomeDB2020YesYes
receptorreceptoriTALKYesYes
receptorreceptorAlmen2009YesYes
Page 5 of 6PreviousNext

Regulatory Interaction Network (1)

1 record.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
BOCQ9BWV1SHHQ15465YesYesHPMRNetPathSignaLink3NetPath:16647304SignaLink3:23331499HPMR:17086203SignaLink3:16647304

Protein Complex Composition (5)

5 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
PTCH2_BOC_transmembrane_receptorBOCPTCH2Q9BWV1Q9Y6C51:1CellPhoneDBCellPhoneDB:PTCH2_BOC_transmembrane_receptor
BOCDHHO43323Q9BWV12:2PDBPDB:3n1g
BOCIHHQ14623Q9BWV11:1PDBPDB:3n1pPDB:3n1m
BOCDENND2CFBXO27HID1Q68D51Q8IV36Q8NI29Q9BWV10:0:0:0hu.MAP2
BOCDENND2CHID1Q68D51Q8IV36Q9BWV10:0:0hu.MAP2

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationMass spectrometry139996590
Sequence, Structure & Domains

Sequences

Length
1,114
Mass
121,059
Sequence
MLRGTMTAWRGMRPEVTLACLLLATAGCFADLNEVPQVTVQPASTVQKPGGTVILGCVVEPPRMNVTWRLNGKELNGSDDALGVLITHGTLVITALNNHTVGRYQCVARMPAGAVASVPATVTLANLQDFKLDVQHVIEVDEGNTAVIACHLPESHPKAQVRYSVKQEWLEASRGNYLIMPSGNLQIVNASQEDEGMYKCAAYNPVTQEVKTSGSSDRLRVRRSTAEAARIIYPPEAQTIIVTKGQSLILECVASGIPPPRVTWAKDGSSVTGYNKTRFLLSNLLIDTTSEEDSGTYRCMADNGVGQPGAAVILYNVQVFEPPEVTMELSQLVIPWGQSAKLTCEVRGNPPPSVLWLRNAVPLISSQRLRLSRRALRVLSMGPEDEGVYQCMAENEVGSAHAVVQLRTSRPSITPRLWQDAELATGTPPVSPSKLGNPEQMLRGQPALPRPPTSVGPASPQCPGEKGQGAPAEAPIILSSPRTSKTDSYELVWRPRHEGSGRAPILYYVVKHRKVTNSSDDWTISGIPANQHRLTLTRLDPGSLYEVEMAAYNCAGEGQTAMVTFRTGRRPKPEIMASKEQQIQRDDPGASPQSSSQPDHGRLSPPEAPDRPTISTASETSVYVTWIPRGNGGFPIQSFRVEYKKLKKVGDWILATSAIPPSRLSVEITGLEKGTSYKFRVRALNMLGESEPSAPSRPYVVSGYSGRVYERPVAGPYITFTDAVNETTIMLKWMYIPASNNNTPIHGFYIYYRPTDSDNDSDYKKDMVEGDKYWHSISHLQPETSYDIKMQCFNEGGESEFSNVMICETKARKSSGQPGRLPPPTLAPPQPPLPETIERPVGTGAMVARSSDLPYLIVGVVLGSIVLIIVTFIPFCLWRAWSKQKHTTDLGFPRSALPPSCPYTMVPLGGLPGHQASGQPYLSGISGRACANGIHMNRGCPSAAVGYPGMKPQQHCPGELQQQSDTSSLLRQTHLGNGYDPQSHQITRGPKSSPDEGSFLYTLPDDSTHQLLQPHHDCCQRQEQPAAVGQSGVRRAPDSPVLEAVWDPPFHSGPPCCLGLVPVEEVDSPDSCQVSGGDWCPQHPVGAYVGQEPGMQLSPGPLVRVSFETPPLTI
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=Q9BWV1-1; Sequence=Displayed; Name=2; IsoId=Q9BWV1-3; Sequence=VSP_034684
Alternative Sequence
514; K -> KQ (in isoform 2)

3D Structural Models

Helix
737..740; 760..762
Beta Strand
717..725; 728..734; 746..754; 764..769; 774..777; 785..794; 805..808
3D Structure
X-ray crystallography (3)

Domain & Motif Annotations

Compositional Bias
820..833; Pro residues; 972..986; Polar residues
Domain (FT)
36..123; Ig-like C2-type 1; 129..213; Ig-like C2-type 2; 235..315; Ig-like C2-type 3; 323..409; Ig-like C2-type 4; 474..571; Fibronectin type-III 1; 608..703; Fibronectin type-III 2; 712..812; Fibronectin type-III 3
Region
422..474; Disordered; 577..615; Disordered; 812..833; Disordered; 972..998; Disordered
Clinical Relevance
Antibody
Supporting Publications1
PMIDTitleRelated sentences
37922300Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women.No related sentences available